XCOVERY
Live / Applied — Third extension granted (statement of use) (as of 04 Sept 2025)
What this means for you
Not registered yet, but its 27 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97812854
- Mark type
- Stylized text
- Filed
- 27 Feb 2023
- Published for opposition
- 09 Jan 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals and agents for the treatment of disease, namely, cancer; pharmaceutical preparations and agents for the treatment of cancer; pharmaceutical preparations and agents used to inhibit kinase for use in the treatment of cancer
- Class 042 — Scientific and technological services: Research and development in the field of biotechnology and oncology; research and development in the field of kinase inhibitors for medical purposes
Owner
- Xcovery Holdings, Inc., Palm Beach Gardens, FL, US
- Xcovery Holdings, Inc., Palm Beach Gardens, FL, US
Prosecution history
- 05 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2025 — SOU EXTENSION 3 GRANTED
- 04 Sept 2025 — SOU EXTENSION 3 FILED
- 04 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2025 — SOU EXTENSION 2 GRANTED
- 05 Mar 2025 — SOU EXTENSION 2 FILED
- 05 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2024 — SOU EXTENSION 1 GRANTED
- 04 Sept 2024 — SOU EXTENSION 1 FILED
- 04 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED